NewGenIvf Group PE Ratio 1970-1969 | NIVF
Current and historical p/e ratio for NewGenIvf Group (NIVF) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NewGenIvf Group PE ratio as of April 30, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
NewGenIvf Group PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-01 | 1.60 | inf |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.007B | $0.000B |
NewGenIvf Limited is a comprehensive fertility services provider principally in Asia helping couples and individuals obtain access to fertility treatments. NewGenIvf, formerly known as A SPAC I Acquisition Corp., is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $122.851B | 15.41 |
Cencora (COR) | United States | $47.686B | 19.03 |
ICON (ICLR) | Ireland | $24.574B | 23.20 |
DiDi Global (DIDIY) | China | $24.011B | 0.00 |
Avantor (AVTR) | United States | $16.459B | 24.23 |
Viatris (VTRS) | United States | $13.776B | 3.96 |
CochLear (CHEOY) | Australia | $13.705B | 0.00 |
Revvity (RVTY) | United States | $12.658B | 22.18 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.086B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.032B | 39.59 |
Charles River Laboratories (CRL) | United States | $11.796B | 21.50 |
Natera (NTRA) | United States | $11.354B | 0.00 |
Solventum (SOLV) | United States | $11.215B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
HealthEquity (HQY) | United States | $6.770B | 50.58 |
Bausch + Lomb (BLCO) | Canada | $5.109B | 19.65 |
Organon (OGN) | United States | $4.786B | 4.61 |
Doximity (DOCS) | United States | $4.531B | 33.74 |
PACS (PACS) | United States | $3.749B | 0.00 |
Surgery Partners (SGRY) | United States | $3.171B | 29.35 |
Sotera Health (SHC) | United States | $3.170B | 15.56 |
Progyny (PGNY) | United States | $3.081B | 51.71 |
GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
Life Times (LTH) | United States | $2.687B | 29.70 |
Premier (PINC) | United States | $2.502B | 9.16 |
AMN Healthcare Services Inc (AMN) | United States | $2.273B | 7.35 |
Agilon Health (AGL) | United States | $2.261B | 0.00 |
Teladoc Health (TDOC) | United States | $2.162B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.830B | 0.00 |
Agiliti (AGTI) | United States | $1.381B | 22.56 |
Establishment Labs Holdings (ESTA) | $1.373B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.317B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.982B | 0.00 |
Pediatrix Medical (MD) | United States | $0.745B | 7.71 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
Enhabit (EHAB) | United States | $0.506B | 45.86 |
Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
LifeMD (LFMD) | United States | $0.488B | 0.00 |
InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.445B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.437B | 0.00 |
MultiPlan (MPLN) | United States | $0.419B | 0.00 |
CareDx (CDNA) | United States | $0.402B | 0.00 |
Beauty Health (SKIN) | United States | $0.399B | 0.00 |
Sera Prognostics (SERA) | United States | $0.379B | 0.00 |
DocGo (DCGO) | United States | $0.352B | 56.33 |
ModivCare (MODV) | United States | $0.333B | 4.42 |
Ascend Wellness Holdings (AAWH) | United States | $0.304B | 0.00 |
Sharecare (SHCR) | United States | $0.259B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.129B | 43.33 |
Oncology Institute (TOI) | United States | $0.079B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |